Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Rvl Pharmaceuticals Plc

Rvl Pharmaceuticals Plc (RVLP)

Market is closed
News
  • Displaying 4

RVL Pharmaceuticals plc (NASDAQ:RVLP) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the RVL Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

August 15th, 2023 - News Transcripts

RVL Pharmaceuticals plc (NASDAQ:RVLP) Q1 2023 Earnings Call Transcript

Operator: Good morning, everyone. My name is Todd, and I will be your conference operator.

Keep Reading →

May 17th, 2023 - News Transcripts

Should You Hold RVL Pharmaceuticals plc (RVLP) for a Potential Upside?

Should You Hold RVL Pharmaceuticals plc (RVLP) for a Potential Upside?

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.

Keep Reading →

March 24th, 2023 - Hedge Fund Investor Letters News

RVL Pharmaceuticals plc (NASDAQ:RVLP) Q4 2022 Earnings Call Transcript

RVL Pharmaceuticals plc (NASDAQ:RVLP) Q4 2022 Earnings Call Transcript

Operator: Good morning everyone. My name is Shelby and I will be your conference Operator.

Keep Reading →

March 22nd, 2023 - News Transcripts

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)